Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
Federico Innocenti, Akram Yazdani, Naim Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2024
<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2019
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)
Heinz-Josef Lenz, Fang-Shu Ou, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2019
Reply to S. Sorscher
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2019
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2019
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer
Robert Piskol, Ling Huw, Ismail Sergin, et al.
Nature Communications
|
May 9, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer
Xueping Qu, Habib Hamidi, Radia M Johnson, et al.
Nature Communications
|
September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
Radia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2010
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Marcin Kowanetz, Xiumin Wu, John Lee, et al.
Communications Medicine
|
January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy
Akram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
Federico Innocenti, Akram Yazdani, Naim Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2024
<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2019
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)
Heinz-Josef Lenz, Fang-Shu Ou, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2019
Reply to S. Sorscher
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2019
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Federico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2019
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer
Robert Piskol, Ling Huw, Ismail Sergin, et al.
Nature Communications
|
May 9, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer
Xueping Qu, Habib Hamidi, Radia M Johnson, et al.
Nature Communications
|
September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
Radia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2010
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Marcin Kowanetz, Xiumin Wu, John Lee, et al.
Communications Medicine
|
January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy
Akram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Page
of 3